55 Results for "

ror1

" in MedChemExpress (MCE) Product Catalog:
Products (55)

55 Results for "ror1" in MCE Product Catalog:

  • Targets Recommended:
  • Recombinant Proteins Recommended:
2
2 Cited Publications
Cat. No.: HY-P99201
CAS No.: 2485779-13-1
Synonyms: UC-961; Cirmtuzumab

Target:  

ROR Wnt

Research Areas:  

Cancer

Zilovertamab (UC-961) is a humanised monoclonal antibody against ROR1 that blocks Wnt5a-induced ROR1 signalling [1].
loading...
    loading...
1
1 Cited Publications
Cat. No.: HY-139534
CAS No.: 3078120-01-8
Purity:  99.16%
Target:  

ROR Apoptosis Akt mTOR PARP

Research Areas:  

Cancer

ARI-1 is a receptor tyrosine kinase-like orphan receptor 1 (ROR1) inhibitor. ARI-1 blocks the PI3K/AKT/mTOR signaling pathway in a ROR1-dependent manner. ARI-1 upregulates cleaved-PARP and p-P38. ARI-1 induces Apoptosis. ARI-1 has anticancer activity against non-small cell lung cancer [1].
loading...
    loading...
Cat. No.: HY-P99956
Synonyms: VLS-101; MK-2140

Research Areas:  

Cancer

Zilovertamab vedotin (VLS-101) is a novel antibody-drug conjugate comprising the humanized monoclonal antibody zilovertamab and and the anti-microtubule cytotoxin monomethyl vedotin. Zilovertamab vedotin binding to tumor cell ROR1 results in rapid internalization, trafficking to lysosomes, antibody–agent conjugate cleavage, and monomethyl vedotin release. Zilovertamab vedotin induces apoptosis. Zilovertamab vedotin can be used in research of cancer [1].
loading...
    loading...
Cat. No.: HY-P99828
CAS No.: 1869928-62-0
Synonyms: PF-06523435; hu24

Target:  

ADC Antibodies RET PERK ROR

Research Areas:  

Cancer

Cofetuzumab (PF-06523435) is a humanized IgG1-κ monoclonal antibody targeting PTK7. The expression system of Cofetuzumab is typically CHO (Chinese hamster ovary) cells. Cofetuzumab downregulates PTK7 expression, modulates its downstream signaling pathways, and inhibits tumor sphere formation of ovarian cancer cells. Cofetuzumab can be used to synthesize the ADC molecule Cofetuzumab pelidotin (HY-P99829). Cofetuzumab is applicable to the research of tumors such as ovarian cancer [1].
loading...
    loading...
Cat. No.: HY-126686
CAS No.: 2259318-51-7
Purity:  99.54%
Research Areas:  

Cancer

Mal-Phe-C4-VC-PAB-MMAE is a drug-linker conjugate for ADC composed of MMAE conjugated to the Mal-Phe-C4-VC-PAB linker. Mal-Phe-C4-VC-PAB-MMAE can be used to synthesize antibody-drug conjugates targeting ROR1, and the resulting ADC exhibits in vitro tumor cell proliferation inhibitory activity. Mal-Phe-C4-VC-PAB-MMAE is applicable to research on cancers expressing ROR1 [1].
loading...
    loading...
Cat. No.: HY-P991209
CAS No.: 2694723-68-5
Synonyms: GNC-035

Target:  

ROR CD3 PD-1/PD-L1

Research Areas:  

Inflammation/Immunology Cancer

Nebratamig (GNC-035) is an anti-ROR1/anti-CD3/anti-PD-L1/anti-4-1BB tetra-specific antibody with potential immunostimulatory and antineoplastic activities [1].
loading...
    loading...
Cat. No.: HY-160806
CAS No.: 2813268-66-3
Research Areas:  

Cancer

(5-Cl)-Exatecan is a derivative of Exatecan (HY-13631) and a DNA topoisomerase inhibitor. (5-Cl)-Exatecan serves as the cytotoxic payload component in antibody-drug conjugates (ADC) targeting ROR1-positive cancers. (5-Cl)-Exatecan is applicable for the research of ROR1-positive cancers [1].
loading...
    loading...
Cat. No.: HY-170995
Target:  

PROTACs ROR Apoptosis

Research Areas:  

Cancer

PROTAC ROR1 degrader-1 is a ROR1 PROTAC degrader with DC50 values of 40.88 nM (NCI-H23), 69.0 nM (NCI-H460), 83.35 nM (NCI-H1299) and 42.07 nM (NCI-H1975), respectively. PROTAC ROR1 degrader-1 inhibits the proliferation of lung cancer cells and induces apoptosis. PROTAC ROR1 degrader-1 can be used in research related to non-small cell lung cancer [1].
loading...
    loading...
Cat. No.: HY-135319
CAS No.: 517-46-4
Purity:  97.15%
Strictinin is an orally active phenolic compound. Strictinin reduces xanthine oxidase activity, uric acid production, and the activation of ERK1/2, JNK, NF-κB, and NLRP3 inflammasome components in hepatocytes treated with Xanthine (HY-W017389). Strictinin decreases elevated serum uric acid levels and enhanced xanthine oxidase activity in mice treated with potassium oxonate. Strictinin acts as a ROR1 inhibitor and exhibits anticancer activity against highly aggressive non-androgen-dependent prostate cancer. Strictinin induces cancer cell apoptosis (apoptosis), arrests cell cycle, and inhibits cancer cell migration, invasion, and epithelial-mesenchymal transition. Strictinin modulates gut microbiota, inhibits bacterial growth and biofilm formation, accelerates small intestinal transit, and blocks viral entry and replication. Strictinin can be used in research related to hyperuricemia, androgen receptor-negative non-androgen-dependent prostate cancer, triple-negative breast cancer, bacterial infections, constipation, coronavirus infections, dental caries, and infections caused by influenza A, influenza B, and human parainfluenza virus type 1 [1] .
loading...
    loading...
Cat. No.: HY-170996
Research Areas:  

Cancer

ROR1 ligand-1 is a ROR1 ligand that can be used for synthesis of PROTACT ROR1 degrader-1 (HY-170995) [1].
loading...
    loading...
Cat. No.: HY-175497
Research Areas:  

Cancer

ROR1-IN-4 is a selective ROR1 inhibitor with a Kd of 52 nM. ROR1-IN-4 shows potent anti-proliferative activity against TNBC cell line MDA-MB-231 (IC50 = 75 nM). ROR1-IN-4 reduces colony formation, induces apoptosis and inhibits the phosphorylation of ROR1 (Tyr786) in MDA-MB-231 cells. ROR1-IN-4 demonstrates superior anti-tumor efficacy in nude mice bearing MDA-MB-231 subcutaneous xenografts. ROR1-IN-4 can be used for the study of triple-negative breast cancer (TNBC) [1].
loading...
    loading...
Cat. No.: HY-174382
Target:  

Akt mTOR NF-κB ROR Apoptosis

Research Areas:  

Cancer

ROR1-IN-3 (Compound 24d) is a potent and highly selective ROR1 kinase inhibitor (IC50 = 17.6 nM). ROR1-IN-3 demonstrates robust antitumor activity and inhibitory effect against ROR1 both in vitro and in vivo. ROR1-IN-3 has robust antiproliferative efficacy in vitro and in vivo. ROR1-IN-3 induces apoptosis in cancer cell lines. ROR1-IN-3 inhibits ROR1 downstream AKT/mTOR and NF-κB signaling pathway. ROR1-IN-3 can be studied in antitumor research [1].
loading...
    loading...
Cat. No.: HY-RS12124
Research Areas:  

Others

ROR1 Human Pre-designed siRNA Set A contains three designed siRNAs for ROR1 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

loading...
    loading...
Cat. No.: HY-RS16801
Research Areas:  

Others

Ror1 Mouse Pre-designed siRNA Set A contains three designed siRNAs for Ror1 gene (Mouse), as well as a negative control, a positive control, and a FAM-labeled negative control.

loading...
    loading...
Cat. No.: HY-162640
CAS No.: 3053223-31-4
Target:  

ROR

Research Areas:  

Cancer

LDR102 (Compound 19h) is an inhibitor for receptor tyrosine kinase-like orphan receptor 1 (ROR 1) with Ki of 0.10 μM. LDR102 inhibits proliferation of cancer cells H1975, A549 and MDA-MB-231, with IC50 of 0.36 μM, 1.37 μM and 0.47 μM. LDR102 exhibits antitumor efficacy in mice and good pharmacokinetic characteristics in rat models [1].
loading...
    loading...
Cat. No.: HY-176190
Target:  

ROR

Research Areas:  

Cancer

ROR1-IN-2 (compound 9I) is a potent and selective ROR1 inhibitor. ROR1-IN-2 exhibits antiproliferative activity in multiple cancer cells. ROR1-IN-2 significantly suppresses tumor growth in vivo [1].
loading...
    loading...
Cat. No.: HY-RS23242
Research Areas:  

Others

Ror1 Rat Pre-designed siRNA Set A contains three designed siRNAs for Ror1 gene (Rat), as well as a negative control, a positive control, and a FAM-labeled negative control.

loading...
    loading...
Cat. No.: HY-161096
CAS No.: 3034861-58-7
Target:  

ROR

Research Areas:  

Cancer

Antitumor agent-127 (compound 1) is a parent macrocyclic peptide. Antitumor agent-127 displays nanomolar cell-based binding to ROR1 and relatively good internalization in 786-O and MDA-MB-231 tumor cell lines [1].
loading...
    loading...
Cat. No.: HY-139534A
CAS No.: 2003228-82-6
Purity:  99.80%
Target:  

Drug Isomer

Research Areas:  

Others

(S)-ARI-1 is an S-enantiomer of ARI-1. ARI-1 is a ROR1 inhibitor and apoptosis inducer, used in NSCLC research [1].
loading...
    loading...
Cat. No.: HY-P84465
Synonyms: ror1

Host:  

Mouse

Application:  

WB, ICC/IF, ELISA

Reactivity:  

Human

loading...
    loading...